ViraTherapeutics' Series A Round

ViraTherapeutics raised a round of funding on June 24, 2015.

ViraTherapeutics is a biopharmaceutical company developing virus-based immunotherapeutics for the treatment of cancer. ViraTherapeutics develops oncolytic cancer vaccines based on chimeric virus deriv…

Articles about ViraTherapeutics' Series A Round: